Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Piloting Pathways, a Hope-enhancing Intervention to Address Activity and Role Function in Metastatic Lung Cancer Patients

NCT04161157 is registered in ClinicalTrials.gov with Laurie McLouth as lead sponsor.

NCT NCT04161157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04161157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Piloting Pathways, a Hope-enhancing Intervention to Address Activity and Role Function in Metastatic Lung Cancer Patients
Lead sponsor
Laurie McLouth
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2020
Completion date
August 3, 2022
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lung cancer